Location History:
- Lyon, FR (1990)
- Francheville, FR (1999 - 2004)
- Montreal, CA (2011)
Company Filing History:
3 out of 1,829 
2 out of 1,744 
1 out of 28 Years Active: 1990-2011
Title: Odile Djossou: Innovator in Monoclonal Antibodies
Introduction
Odile Djossou is a prominent inventor based in Francheville, France. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 6 patents to her name, her work has advanced the understanding and application of human CTLA-8.
Latest Patents
Djossou's latest patents include groundbreaking innovations such as monoclonal antibodies to human CTLA-8 (IL-17A). These patents cover the human CTLA-8 protein, antibodies that specifically bind to human CTLA-8, and nucleic acids encoding human CTLA-8. Additionally, she has developed methods for using these molecules and diagnostic kits. Another significant patent involves nucleic acids encoding CTLA-8 and related reagents, including purified proteins, specific antibodies, and nucleic acids encoding said antigen. The methods of using these reagents and diagnostic kits are also provided in her patents.
Career Highlights
Throughout her career, Odile Djossou has worked with notable organizations, including Schering Corporation. Her expertise in biotechnology has positioned her as a key figure in the development of innovative medical solutions.
Collaborations
Djossou has collaborated with esteemed colleagues such as Francois Fossiez and Jacques F. Banchereau. These partnerships have further enhanced her research and contributions to the field.
Conclusion
Odile Djossou's work in monoclonal antibodies and her innovative patents have made a significant impact in biotechnology. Her contributions continue to influence the development of diagnostic and therapeutic solutions.